Back to Authors

Kaufmann, Scott H.

https://orcid.org/0000-0002-4900-7145

A5054370710 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 321

Faculty Opinions recommendation of Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725369660.793525483

Faculty Opinions recommendation of Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725314829.793525479

Faculty Opinions recommendation of Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718479856.793525482

Faculty Opinions recommendation of Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718232311.793525481

Faculty Opinions recommendation of Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726638619.793525472

Faculty Opinions recommendation of HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726620288.793525473

Faculty Opinions recommendation of Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726290880.793525477

Faculty Opinions recommendation of Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725818536.793525478

Faculty Opinions recommendation of Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725259936.793525474

Faculty Opinions recommendation of Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.722006164.793525476